
A Pan-Cancer Analysis of Natriuretic Peptide Receptor 3 (NPR3) with Clinical Cohort and in vitro Validation
Introduction Cancer has become a major global public health concern, imposing substantial socioeconomic burdens. In 2024, an estimated 2,001,140 new cancer cases occurred in the United States alone.1 Despite the large number of patients requiring effective …